Patents by Inventor Susanne Zuleger

Susanne Zuleger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isophthalic acid derivatives
    Patent number: 7498460
    Abstract: The present invention relates to isophthalic acid derivatives, to a process for their preparation and to their use for producing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular of cardiovascular disorders.
    Type: Grant
    Filed: November 28, 2003
    Date of Patent: March 3, 2009
    Assignee: Bayer Healthcare AG
    Inventors: Michael Härter, Jens Ergüden, Frank Wunder, Hanna Tinel, Johannes Köbberling, Eva-Maria Becker, Klaus Münter, Karl-Heinz Schlemmer, Raimund Kast, Peter Kolkhof, Gunter Karig, Lars Bärfacker, Walter Hübsch, Joachim Schuhmacher, Susanne Zuleger, Arnel Concepcion, Haruka Shimizu
  • Formulations with Controlled Release of Active Ingredient
    Publication number: 20080268046
    Abstract: The present invention relates to novel pharmaceutical dosage forms with controlled release of active ingredient which comprise the PDE 5 inhibitor vardenafil and/or pharmaceutically acceptable salts, hydrates, solvates and/or polymorphic forms thereof as active ingredient, and to the production thereof. The invention further relates to the use of these novel pharmaceutical dosage forms as medicaments, and to their use for producing medicaments for the treatment and/or prevention of disorders in humans and animals.
    Type: Application
    Filed: April 29, 2005
    Publication date: October 30, 2008
    Applicant: BAYER HEALTHCARE AG
    Inventors: Susanne Zuleger, Peter Serno, Helmut Haning, Kerstin Pauli, Roland Heinig
  • Formulations With Controlled Release Of Active Ingredient
    Publication number: 20080187588
    Abstract: The present invention relates to novel pharmaceutical dosage forms with controlled release of active ingredient which comprise the PDE 5 inhibitor vardenafil and/or pharmaceutically acceptable salts, hydrates, solvates and/or polymorphic forms thereof as active ingredient, and to the production thereof. The invention further relates to the use of these novel pharmaceutical dosage forms as medicaments, and to their use for producing medicaments for the treatment and/or prevention of disorders in humans and animals.
    Type: Application
    Filed: May 10, 2005
    Publication date: August 7, 2008
    Applicant: Bayer HealthCare AG
    Inventors: Susanne Zuleger, Peter Serno, Helmut Haning, Kerstin Pauli, Roland Heinig
  • Isophtalic acid derivatives
    Publication number: 20060154912
    Abstract: The present invention relates to isophthalic acid derivatives, to a process for their preparation and to their use for producing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular of cardiovascular disorders.
    Type: Application
    Filed: November 28, 2003
    Publication date: July 13, 2006
    Inventors: Michael Harter, Jens Erguden, Frank Wunder, Hanna Tinel, Johannes Kobberling, Eva-Maria Becker, Klaus Munter, Karl-Heinz Schlemmer, Raimund Kast, Peter Kolkhof, Gunter Karig, Lars Barfacker, Walter Hubsch, Joachim Schuhmacher, Susanne Zuleger, Arnel Concepcion, Haruka Shimizu
  • Pharmaceutical compositions for the treatment of hyper-proliferative disorders
    Publication number: 20060058358
    Abstract: This invention relates to novel pharmaceutical compositions comprising a solid dispersion of the compound of Formula I below, to processes for preparing these novel pharmaceutical compositions and to their use for treating hyper-proliferative disorders, such as cancer, either as a sole agent or in combination with other therapies.
    Type: Application
    Filed: August 26, 2005
    Publication date: March 16, 2006
    Inventors: Jacques Dumas, Paul Ehrlich, Susanne Zuleger
  • Stents with vitronectin receptor antagonists against restenosis
    Publication number: 20040236413
    Abstract: The application relates to vitronectin receptor antagonist-containing stents and to their production and use.
    Type: Application
    Filed: June 28, 2004
    Publication date: November 25, 2004
    Inventors: Klaus Urbahns, Christoph Gerdes, Susanne Zuleger, Sabine Gelfert-Peukert, Jeffrey Low, Jochen Kalbe